Another cancer injectable drug goes into shortage
(By Paige Twenter for Becker’s Hospital Review ) Multiple solutions of etoposide, an injectable used for testicular and small cell
Read More
Part D/Prescription Drugs
3 Charts About Medicare Drug Price Negotiations
(Chris Lee for The Kaiser Family Foundation published January 31, 2024) Under the Inflation Reduction Act, the federal government for
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Jan 31, 2024) The Inflation Reduction Act of 2022 (the Act),
Read MoreCMS proposes Medicare Advantage rate cut
(By Rylee Wilson for Becker’s Hospital Review ) CMS proposed a slight decrease in Medicare Advantage benchmark payments for 2025.
Read More10 Reasons Why Medicare Advantage Enrollment is Growing and Why It Matters
(By Tricia Neuman, Meredith Freed, and Jeannie Fuglesten Biniek for The Kaiser Family Foundation Published: Jan 30, 2024) For the
Read MoreThe FTC Is Attacking Drugmakers’ ‘Patent Thickets’
(By Elisabeth Rosenthal for KFF Health News) The Federal Trade Commission has challenged the validity of over 100 drug product
Read MoreWhat to Watch in 2024: The Latest Health Cost and Affordability Issues and Trends
(By Tammie Smith for The Kaiser Family Foundation published January 24, 2024) While issues of health care costs and affordability
Read MoreIs a Medicare Advantage plan right for you?
More than half, or 51 percent, of eligible Medicare recipients enrolled in a Medicare Advantage plan. So, what makes Medicare
Read MoreCurious about Medicare Advantage?
Are you turning 65 this year and confused about Medicare and Medicare Advantage; you are not alone. It is good
Read MoreWhat to know about January’s annual drug price hikes
(By Sydney Lupkin for NPR) Drug companies often increase prices at the start of the new year, and 2024 seems
Read More